THE LEVEL OF PRO-INFLAMMATORY CYTOKINES IN FETAL GROWTH RETARDATION

LEYLA M. RZAKULIEVA; SAMIRA A. AKPERBEKOVA; GUNAY A. SAFAROVA

doi:10.52340/jecm.2023.05.33

THE LEVEL OF PRO-INFLAMMATORY CYTOKINES IN FETAL GROWTH RETARDATION

Авторы

LEYLA M. RZAKULIEVA
SAMIRA A. AKPERBEKOVA
GUNAY A. SAFAROVA

DOI:

https://doi.org/10.52340/jecm.2023.05.33

Ключевые слова:

fetal growth retardation, placental insufficiency, pro-inflammatory cytokines

Аннотация

The purpose of the study is to evaluate the level of pro-inflammatory cytokines in the blood of pregnant women with late intrauterine growth retardation (IGR). We examined 94 pregnant women with IGR at 36-37 weeks, mean age 30.2±1.88 years. All pregnant women underwent Doppler ultrasound in the third trimester. The determination of interferon-γ (IFN-γ), interleukin 1β (IL-1β), tumor necrosis factor-alpha (TNF-α) was performed in blood serum by ELISA. In 51.1% of cases, grade 1 IGR was diagnosed, in 48.9% of cases - grade II IGR. According to Doppler ultrasound, pregnant women with IGR more often (31.9%) had changes in the cerebral-placental ratio. Late IGR was diagnosed in 38.3% of pregnant women (group I), late IGR accompanied by placental insufficiency - in 61.7% of women (group II). The level of INF-γ was higher than the control, but a significant difference with the control was noted in patients of group II (p=0.054). The level of IL-1β in the total sample was higher than the control by 69.6% (p<0.001), in groups I and II - by 60.9% (p=0.006) and 74.4% (p<0.001), respectively. In patients of group II, compared with group I, the level of IL-1β exceeded by 31.9% (p=0.090). The content of TNF-α in all groups significantly exceeded the control value. A high level of TNF-α was observed in group II compared with group I (p=0.010). With fetal growth retardation, there is an increase in pro-inflammatory immunity, manifested in an increase in the levels of TNF-α, IL-1-β and IFN-γ.

Скачивания

Данные скачивания пока недоступны.

Библиографические ссылки

Al-Azemi M, Raghupathy R, Azizieh F. Pro-inflammatory and anti-inflammatory cytokine profiles in fetal growth restriction. Clin Exp Obstet Gynecol. 2017;44(1):98-103.

Azizieh F, Dingle K, Raghupathy R, et al. Multivariate Analysis of Cytokine Profiles in Pregnancy Complications. Am J Reprod Immunol. 2018;79:e12818. doi: 10.1111/aji.12818.

Jarmund AH, Giskeødegård GF, et al. Cytokine Patterns in Maternal Serum From First Trimester to Term and Beyond. Front Immunol. 2021;12:752660. doi: 10.3389/fimmu.2021.752660.

Kamphof HD, Posthuma S, Gordijn SJ, Ganzevoort W. Fetal Growth Restriction: Mechanisms,Epidemiology, and Management. Maternal-Fetal Medicine. 2022;4(3):186-196. doi: 10.1097/FM9.0000000000000161.

Kirici P, Çağiran FT, Kali Z, Tanriverdi EF, Mavral N, Ecin SM. Determination of maternal serum pro-inflammatory cytokine changes in intrauterine growth restriction. European Review for Medical and Pharmacological Sciences. 2023;27(5):1996-2001. doi: 10.26355/eurrev_202303_31565.

Kudryavtseva E.V., Kovalev V.V., Dektyarev A.A., Baranov I.I. Predicting fetal growth retardation: mathematical modeling. Obstetrics, Gynecology and Reproduction. 2022;16(6):664–675. (In Russ.). doi: 10.17749/2313-7347/ob.gyn.rep.2022.328.

Mavlyanova NN, Iхtiyarova GI, Tosheva I.I, Aslonova M Zh, Narzullaeva N. The State of the Cytokine Status in Pregnant Women with Fetal Growth Retardation. J Med-Clin Res & Rev.2020;4(6):1-4.

Melamed N, Baschat A, Yinon Y, et al. FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction. Gynecology & Obstetrics. 2021;152(S1):3-57. doi: 10.1002/ijgo.13522.

Monteith C, Flood K, Pinnamaneni R, Levine TA, et al. An abnormal cerebroplacental ratio (CPR) is predictive of early childhood delayed neurodevelopment in the setting of fetal growth restriction. Am J Obstet Gynecol. 2019;221(3):273.e1-273.e9. doi: 10.1016/j.ajog.2019.06.026.

Nardozza LM, Caetano AC, Zamarian AC, Mazzola JB, Silva CP, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet 2017;295(5):1061-1077.

Spence T, Allsopp PJ, Yeates AJ, et al. Maternal Serum Cytokine Concentrations in Healthy Pregnancy and Preeclampsia. J Pregnancy. 2021;2021:6649608. doi: 10.1155/2021/6649608.

Stokkeland LMT, Giskeødegård GF, Stridsklev S, et al. Serum Cytokine Patterns in First Half of Pregnancy. Cytokine. 2019;119:188–96. doi: 10.1016/j.cyto.2019.03.013.

Weel IC, Baergen RN, Romão-Veiga M, Borges VT, Ribeiro VR, Witkin SS, et al. Association Between Placental Lesions, Cytokines and Angiogenic Factors in Pregnant Women With Preeclampsia. PloS One. 2016;11:e0157584. doi: 10.1371/journal.pone.0157584.

Yockey L.J., Iwasaki A. Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development. Immunity. 2018;49(3):397-412. doi: 10.1016/j.immuni.2018.07.017.